Skip to main content
logo
BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
3.310
-0.110 (-3.22%)
At close: Oct 9, 2026, 4:00 PM EDT
3.350
+0.040 (1.21%)
After-hours: Oct 9, 2026, 7:30 PM EDT

BBOT Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Net Income
-182.11-134.04-74.28-64.7
Depreciation & Amortization
0.750.610.210.09
Loss (Gain) From Sale of Investments
-0.13-1.26-1.54-
Stock-Based Compensation
15.475.874.4316.47
Other Operating Activities
7.788.490.56-
Change in Accounts Payable
5.03-1.842.50.27
Change in Other Net Operating Assets
1.948.2713.1-4.2
Operating Cash Flow
-151.28-113.89-55.03-52.08
Operating Cash Flow Growth
----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Capital Expenditures
-0.28-0.61-0.05-0.41
Investment in Securities
-191.0773.93-122.89-
Other Investing Activities
--2.41-2.41
Investing Cash Flow
-191.3673.33-120.53-2.82

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Issuance of Common Stock
373.96373.51.113.62
Other Financing Activities
-8.77-12.32--
Financing Cash Flow
365.18383.4206.2955.12

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Net Cash Flow
22.55342.8430.730.23

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Free Cash Flow
-151.56-114.5-55.08-52.49
Free Cash Flow Growth
----
Free Cash Flow Per Share
-2.13-3.68-4268.47-420.87
Levered Free Cash Flow
-89.98-74.19-42.53-
Unlevered Free Cash Flow
-89.98-74.19-42.53-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Change in Working Capital
6.976.4315.59-3.94